Enovix Earnings Call: Progress, Cash, and Bottlenecks

Enovix Corporation ((ENVX)) has held its Q1 earnings call. Read on for the main highlights of the call.

Enovix Corporation’s latest earnings call struck a cautiously optimistic tone as management balanced notable technical and commercial wins with persistent financial losses and manufacturing bottlenecks. Revenue growth, rising gross margins and a strong cash war chest are helping investors look past near‑term cash burn and slower qualification timelines in smartphones.

Smart Eyewear Production Begins, Market Potential Looms

Enovix has started commercial production of its A1 silicon‑anode battery for a lead smart eyewear customer, with initial shipments already underway and a ramp expected through the second half of 2026. The company sees about 50,000 eyewear units next year, with the broader market potentially topping $1 billion by 2030, making today’s volumes a strategic beachhead.

Smartphone OEMs Align on New Qualification Framework

The company has aligned with Honor and a second smartphone OEM on a silicon‑anode specific qualification regime that emphasizes 0.1–0.2C tests instead of legacy 0.7C protocols. While this better reflects real‑world usage and cycle life, it slows testing and could extend timelines before large‑scale smartphone launches materialize.

Revenue Surges and Margins Continue to Improve

Q1 revenue rose 49% year over year to $7.6 million, topping the high end of guidance and marking the sixth straight quarter of positive gross profit on both GAAP and non‑GAAP bases. Non‑GAAP gross margin reached 26.3%, signaling early leverage as the company moves from development toward broader commercialization.

Robust Cash Pile Extends Liquidity Runway

Enovix ended Q1 with roughly $582.7 million in cash, equivalents, restricted cash and marketable securities, giving it significant runway to fund commercialization and capacity build‑out. Management emphasized that this liquidity supports both manufacturing scale‑up and selective strategic opportunities without immediate pressure to raise capital.

Manufacturing Yields Improve as Dicing Bottleneck Persists

Production yields in most manufacturing zones are nearing or surpassing 90%, reflecting steady process refinement. However, Zone 1 dicing remains a throughput bottleneck at about 80% yield, and management is banking on a hybrid laser‑mechanical dicing solution to lift throughput and lower unit costs once fully deployed.

AI2 Samples Deliver Significant Energy Density Gains

The company produced its first AI2 engineering samples for smart eyewear, achieving more than 20% higher volumetric energy density than AI1 by trimming inactive material and raising cathode voltage. Enovix also highlighted independent validation of its AI1 smartphone battery at 935 Wh/L, reinforcing its performance claims to handset OEMs.

MX Platform Targets High‑Performance Drone Market

Enovix launched the MX1‑B01 cell for drones, boasting 360 Wh/kg and about 300 cycles while being manufactured in Korea and compliant with defense‑focused sourcing rules. The Korean pipeline now exceeds $130 million, mostly from drone demand, and the company is aiming for an MX2 product reaching 400 Wh/kg by 2027.

Commercial Build‑Out and Vertical Integration Strategy

To accelerate revenue conversion, Enovix appointed Steve Bakos as SVP of Worldwide Sales and is leaning on vertically integrated manufacturing in Korea and Malaysia to satisfy defense and industrial customers. Management reiterated Q2 2026 revenue guidance of $8–$9 million alongside targeted capital spending to expand capacity in its owned facilities.

Operating Losses and Negative EBITDA Remain a Drag

Despite operational progress, the income statement remains firmly in the red, with non‑GAAP operating expenses at $30.8 million and a non‑GAAP loss from operations of $28.8 million in Q1. Adjusted EBITDA was negative $20.3 million and roughly flat year over year, underscoring that profitability is still several years away.

Cash Burn Driven by Interest and Inventory Build

Free cash flow outflow reached $36.3 million in Q1, driven largely by the semiannual interest payment on 2030 convertible notes and higher inventory levels in Korea to support upcoming shipments. While manageable against the current cash balance, this elevated burn rate will remain a key metric for investors monitoring execution risk.

Dicing Throughput and Cost Challenges in Focus

Zone 1’s laser‑based dicing process still constrains throughput and inflates unit costs, even as yields slowly improve from around 80%. Management views the planned hybrid mechanical dicing rollout next year as critical to unlocking higher volumes and better economics, but it remains a near‑term execution risk.

Longer Testing Protocols Stretch Qualification Timelines

Shifting to slower 0.1–0.2C cycle tests brings Enovix closer to real‑world smartphone usage but also means qualification campaigns take longer to complete. Some specialized stress tests, such as extreme temperature power scenarios, require additional work and may further delay first commercial launches in handsets.

Limited Near‑Term Volumes in Smartphones and Eyewear

Initial Honor field tests are expected to be small, likely only in the thousands of units, with a meaningful smartphone ramp not anticipated until 2027. Smart eyewear shipments around 50,000 units in 2026 will showcase technology but contribute modestly to revenue compared with the long‑term addressable market.

CapEx Set to Rise After Timing‑Driven Q1 Lull

Capital expenditures were just $3.2 million in Q1, below prior expectations due to timing shifts in payments. Management now guides Q2 CapEx to $9–$13 million, reflecting deferred spending and the first wave of investment for capacity expansion in Korea, which will lift near‑term cash outflows.

Disciplined M&A Approach Limits Inorganic Growth

While management reports an active pipeline of potential acquisitions, they stressed price discipline and noted that several opportunities were rejected. With no deals closed, Enovix’s growth story remains predominantly organic, dependent on converting its technology lead into scaled commercial programs.

Guidance Signals Steady Growth Amid Continued Losses

For Q2 2026, Enovix guided revenue to $8–$9 million, up sequentially from Q1, and expects a non‑GAAP loss from operations between $29 million and $32 million with net loss per share of $0.13–$0.17. CapEx is projected at $9–$13 million as it ramps capacity, suggesting ongoing losses but measured top‑line progress and continued investment in scale.

Enovix’s earnings call painted a picture of a company crossing from lab to market, with strong technology validation, rising revenue and ample cash offset by operational hurdles and extended timelines. For investors able to tolerate near‑term volatility and cash burn, the combination of high‑performance batteries, growing customer engagement and a solid balance sheet supports a cautiously constructive long‑term thesis.